Agilent Technologies (A) Q1 2026 10-Q Quarterly Report

Filed: Mar 3, 2026Period ending Jan 31, 2026
Health Care
Laboratory Analytical InstrumentsSEC EDGAR

Agilent Technologies (A) 10-Q quarterly report for Q1 2026, filed with SEC EDGAR on Mar 3, 2026 for the fiscal period ending Jan 31, 2026. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

Agilent Technologies Q1 2026 10-Q Analysis

Management Discussion & Analysis

  • Revenue $1,798M, up 7% YoY; services +9%, products +6%; 3 ppt tailwind from FX
  • Overall operating margin 19.7% vs 22.4% YoY; gross margin 52.6% vs 53.5%; tariffs, restructuring costs, SG&A surge (+16%) key drags
  • Best segment: Agilent CrossLab +9% revenue, operating margin 31.6% vs 31.8% YoY; worst: Life Sciences & Diagnostics operating margin 16.0% vs 18.1% YoY
  • Operating cash flow $268M vs $431M YoY; cash $1,758M; $152M buybacks + $72M dividends deployed; capex $93M
  • Mgmt expects to fully offset FY26 tariff cost impact via pricing/supply chain; flags U.S. federal government customers as spending headwind; cautious on evolving trade policy uncertainty

Risk Factors

  • Tariff/trade risk materially escalated — new explicit language on U.S.-China tariffs, retaliatory measures, and potential trade war with uncertain scope and duration
  • Regulatory risk: GDPR fines up to 4% of total company revenue; also subject to China PIPL, CCPA, and Brazil LGPD across multiple jurisdictions
  • Government funding disruption risk added — federal agency budget cuts, workforce reductions, and shutdowns could impair customers reliant on U.S. federal funding
  • AI integration risk newly detailed — risks of biased algorithms, IP leakage, data privacy violations, and rapidly evolving regulatory environment with uncertain compliance costs
  • Liquidity/debt: $3.4B outstanding indebtedness as of Jan 31, 2026, including $3.3B unsecured senior notes; $1.8B cash held in money market and deposit accounts

Agilent Technologies Q1 2026 Quarterly Financials
XBRL

Revenue

$1.8B

+7.0% YoY

Net Income

$305M

-4.1% YoY

Operating Margin

19.6%

-273bp YoY

Net Margin

17.0%

-195bp YoY

ROE

4.4%

Total Assets

$12.8B

+0.7% QoQ

EPS (Diluted)

$1.07

-3.6% YoY

Operating Cash Flow

$268M

-37.8% YoY

Source: XBRL data from Agilent Technologies Q1 2026 10-Q filing on SEC EDGAR. All figures in USD.

Other Agilent Technologies Quarterly Reports

Get deeper insights on Agilent Technologies

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.